CSF2 and autoimmune pulmonary alveolar proteinosis: Moreover, it has been reported that inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) can be an effective therapy for autoimmune PAP in a double-blind, placebo-controlled, and three-group trial [4].